Harvard, MA, United States of America

Kenneth P Gall

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 3.0

ph-index = 16

Forward Citations = 1,195(Granted Patents)


Location History:

  • Harvard, MA (US) (2007 - 2019)
  • Somerville, MA (US) (2019 - 2020)

Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kenneth P. Gall in Medical Technology

Introduction: Kenneth P. Gall, based in Harvard, MA, is a prolific inventor with a remarkable portfolio of 28 patents. His work primarily focuses on advancements in medical technology, particularly in particle acceleration and treatment systems, which have vast implications for healthcare and therapeutic interventions.

Latest Patents: Among his latest innovations are two significant patents: the "Interrupted Particle Source" and the "Inner Gantry". The Interrupted Particle Source describes a synchrocyclotron that incorporates magnetic structures to generate a magnetic field within a cavity. This device utilizes a particle source to create a plasma column, which is strategically designed with a housing that is interrupted at an acceleration region to expose the plasma. Additionally, it connects to a voltage source to deliver a radio frequency (RF) voltage, enabling the acceleration of particles for treatment purposes.

The Inner Gantry patent highlights a sophisticated system comprising a patient support and an outer gantry equipped with an accelerator. This design facilitates the movement of the accelerator around a patient, allowing it to produce a proton or ion beam at energy levels high enough to target specific areas within the patient. The inner gantry features an aperture directed towards the treatment target, showcasing advanced engineering for precision medicine.

Career Highlights: Kenneth P. Gall has a distinguished career, having worked at notable companies such as Mevion Medical Systems, Inc. and Still River Systems Incorporated. His contributions in these organizations have helped propel innovations in the field of particle therapy, significantly enhancing cancer treatment capabilities.

Collaborations: During his career, Gall has collaborated with esteemed colleagues including Stanley J. Rosenthal and Gerrit Townsend Zwart. Their joint efforts have contributed to the advancement of particle therapy technologies, fostering an environment of innovation and research in therapeutic applications.

Conclusion: Kenneth P. Gall's innovative spirit and dedication to advancing medical technology have made a substantial impact in the field. With 28 patents to his name that focus on particle acceleration and treatment systems, his contributions continue to shape the future of healthcare, underlining the vital role of inventors in driving progress and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…